NEOS Investment Management LLC Has $3.23 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

NEOS Investment Management LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 30.1% in the fourth quarter, HoldingsChannel reports. The fund owned 10,744 shares of the company’s stock after buying an additional 2,487 shares during the period. NEOS Investment Management LLC’s holdings in HCA Healthcare were worth $3,225,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in HCA. MML Investors Services LLC grew its position in shares of HCA Healthcare by 31.7% during the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after buying an additional 4,285 shares during the period. Meritage Group LP acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at $150,548,000. Galvin Gaustad & Stein LLC bought a new stake in HCA Healthcare in the fourth quarter valued at about $18,044,000. NRI Wealth Management LC acquired a new position in shares of HCA Healthcare during the 4th quarter worth about $2,896,000. Finally, Czech National Bank raised its position in shares of HCA Healthcare by 4.5% in the 4th quarter. Czech National Bank now owns 39,543 shares of the company’s stock valued at $11,869,000 after acquiring an additional 1,691 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.0 %

Shares of HCA stock opened at $342.25 on Friday. The firm’s 50-day moving average is $324.53 and its 200-day moving average is $341.56. The stock has a market cap of $84.26 billion, a price-to-earnings ratio of 15.58, a PEG ratio of 1.10 and a beta of 1.68. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the firm posted $5.90 EPS. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a $0.72 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.84%. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.30% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Truist Financial reduced their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Cantor Fitzgerald reiterated an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a report on Monday, January 27th. Bank of America dropped their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Barclays dropped their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Finally, KeyCorp reduced their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.